How different peptide therapies may affect your body Prenuvo blog Q&A: Should you trust trending peptide injections? The Peptide Boom Is Getting Out of Hand The Atlantic In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, The Pharmacology of Longevity: Peptide Edition (Part 1)